These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32060221)

  • 41. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Microbiological aspects of the pharmaceutical environment].
    Buogo A; Guerrato G; Giulioni A; Papakristo G
    Boll Chim Farm; 1979 Jan; 118(1):9-17. PubMed ID: 454532
    [No Abstract]   [Full Text] [Related]  

  • 44. Good design practices for an integrated containment and production system for advanced therapies.
    Zanini C; Severina F; Lando G; Fanizza C; Cesana E; Desidera D; Bonifacio M
    Biotechnol Bioeng; 2020 Aug; 117(8):2319-2330. PubMed ID: 32374459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In support of settle plates.
    Whyte W
    PDA J Pharm Sci Technol; 1996; 50(4):201-4. PubMed ID: 8810833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Environmental microbial challenges to an aseptic Blow-Fill-Seal process--a practical study.
    Jones DJ; Topping P; Sharp J
    PDA J Pharm Sci Technol; 1995; 49(5):226-34. PubMed ID: 7489196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of blow/fill/seal equipment under controlled airborne microbial challenges.
    Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 1995; 49(6):294-9. PubMed ID: 8581461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbiological monitoring of hepatocyte isolation in the GMP laboratory.
    Lehec SC
    Methods Mol Biol; 2009; 481():221-7. PubMed ID: 19096798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic review and meta-analysis of the risk of microbial contamination of aseptically prepared doses in different environments.
    Austin PD; Elia M
    J Pharm Pharm Sci; 2009; 12(2):233-42. PubMed ID: 19732500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
    Jiang M; Severson KA; Love JC; Madden H; Swann P; Zang L; Braatz RD
    Biotechnol Bioeng; 2017 Nov; 114(11):2445-2456. PubMed ID: 28710854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
    Geersing TH; Franssen EJF; Pilesi F; Crul M
    Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination.
    Shintani H
    Biocontrol Sci; 2016; 21(2):63-72. PubMed ID: 27350424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacterial endotoxin requirements for dry powder inhalants and their excipients: are they critical quality attributes?
    Cundell AM
    PDA J Pharm Sci Technol; 2014; 68(5):386-93. PubMed ID: 25336414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microbiological quality control of some non-sterile preparations commonly used in Pakistan.
    Rauf A; Erum A; Noreen S; Shujaat J; Ashraf MU; Afreen S
    Pak J Pharm Sci; 2018 Jul; 31(4):1237-1242. PubMed ID: 30033406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Total organic carbon (VCSN and VWP) and HPLC analysis for cleaning validation in a pharmaceutical pilot plant.
    Queralt M; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Miñarro M; Ticó JR
    PDA J Pharm Sci Technol; 2009; 63(1):42-57. PubMed ID: 19455941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. One-way distribution system for water for injection: process management, microbiological quality control, and meeting regulatory requirements.
    Jahnke M
    PDA J Pharm Sci Technol; 2001; 55(1):3-9. PubMed ID: 11212418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Method Verification Requirements for an Advanced Imaging System for Microbial Plate Count Enumeration.
    Jones D; Cundell T
    PDA J Pharm Sci Technol; 2018; 72(2):199-212. PubMed ID: 29242391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aseptic processing contamination case studies and the pharmaceutical quality system.
    Friedman RL
    PDA J Pharm Sci Technol; 2005; 59(2):118-26. PubMed ID: 15971544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. People as a Contamination Source in Pharmaceutical Clean Rooms-Source Strengths and Calculated Concentrations of Airborne Contaminants.
    Ljungqvist B; ReinmÜller B
    PDA J Pharm Sci Technol; 2021; 75(2):119-127. PubMed ID: 32999075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.